Paper40326486
Treatment With Inhaled Nitric Oxide and General Intelligence in Preterm Children in Two European Cohorts.
Tsalacopoulos N and 12 others. Acta Paediatr, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Treatment With Inhaled Nitric Oxide and General Intelligence in Preterm Children in Two European Cohorts. Papers, record 40326486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40326486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment With Inhaled Nitric Oxide and General Intelligence in Preterm Children in Two European Cohorts.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nitric Oxide | Major topic |
| Intelligence | Major topic |
| Humans | |
| Child, Preschool | |
| Female | |
| Infant, Newborn | |
| Male | |
| Child | |
| Administration, Inhalation | |
| Infant, Premature | |
| Cohort Studies |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 847941 | European Commission | PubMed | ||
| 01ER0805 | Bundesministerium für Bildung und Forschung | PubMed | ||
| 01ER1501 | Bundesministerium für Bildung und Forschung | PubMed | ||
French Institute of Public Health Research/Institute of Public Health and its partners: the French Health Ministry, the National Institutes of Health and Medical Research (INSERM), the National Institute of Cancer, and the National Solidarity Fund for Autonomy (CNSA) | PubMed | |||
| ANR-11-EQPX-0038 | National Research Agency through the French EQUIPEX program of investments in the future | PubMed | ||
| ANR-19-COHO001 | National Research Agency through the French EQUIPEX program of investments in the future | PubMed | ||
| PREMUP Foundation | PubMed | |||
| 11779 | Fondation de France | PubMed | ||
| SPF20160936356 | Fondation pour la Recherche Médicale | PubMed | ||
| DGOS13-040 | Program Hospitalier de Recherche Clinique Epinutri | PubMed | ||
| G13129KK | Ministére de l'Enseignement Supérieur, De La Recherche et de L'Innovation | PubMed | ||
| R20065KK | Apicil Foundation | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37261390 | New Horizons: Gonadotropin-Releasing Hormone and Cognition. | J Clin Endocrinol Metab | 2023 | https://conductscience.org/library/papers/37261390 | PubMed |
| 2 | 38273818 | Efficacy of inhaled nitric oxide in preterm infants ≤ 34 weeks: a systematic review and meta-analysis of randomized controlled trials. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38273818 | PubMed |
| 3 | 29803690 | Pregnancy care in Germany, France and Japan: an international comparison of quality and efficiency using structural equation modelling and data envelopment analysis. | Public Health | 2018 | https://conductscience.org/library/papers/29803690 | PubMed |
| 4 | 28045472 | Inhaled nitric oxide for respiratory failure in preterm infants. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28045472 | PubMed |
| 5 | 30674051 | Birth Size and Gestational Age Specific Outcomes of Inhaled Nitric Oxide Therapy in Preterm Neonates with Clinically Diagnosed Pulmonary Hypertension. | Am J Perinatol | 2019 | https://conductscience.org/library/papers/30674051 | PubMed |
| 6 | 24716860 | EPIPAGE 2: a preterm birth cohort in France in 2011. | BMC Pediatr | 2014 | https://conductscience.org/library/papers/24716860 | PubMed |
| 7 | 23910570 | Effects of sensitive parenting on the academic resilience of very preterm and very low birth weight adolescents. | J Adolesc Health | 2013 | https://conductscience.org/library/papers/23910570 | PubMed |
| 8 | 18375612 | The INNOVO multicentre randomised controlled trial: neonatal ventilation with inhaled nitric oxide versus ventilatory support without nitric oxide for severe respiratory failure in preterm infants: follow up at 4-5 years. | Arch Dis Child Fetal Neonatal Ed | 2008 | https://conductscience.org/library/papers/18375612 | PubMed |
| 9 | 36061415 | Fentanyl Exposure in Preterm Infants: Five-Year Neurodevelopmental and Socioemotional Assessment. | Front Pain Res (Lausanne) | 2022 | https://conductscience.org/library/papers/36061415 | PubMed |
| 10 | 28973344 | Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. | JAMA Pediatr | 2017 | https://conductscience.org/library/papers/28973344 | PubMed |
| 11 | 38436980 | Mini-Puberty, Physiological and Disordered: Consequences, and Potential for Therapeutic Replacement. | Endocr Rev | 2024 | https://conductscience.org/library/papers/38436980 | PubMed |
| 12 | 36863329 | European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. | Neonatology | 2023 | https://conductscience.org/library/papers/36863329 | PubMed |
| 13 | 19960510 | Improving propensity score weighting using machine learning. | Stat Med | 2010 | https://conductscience.org/library/papers/19960510 | PubMed |
| 14 | 26534956 | Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. | Circulation | 2015 | https://conductscience.org/library/papers/26534956 | PubMed |
| 15 | 32892178 | Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial. | J Perinat Med | 2020 | https://conductscience.org/library/papers/32892178 | PubMed |
| 16 | 38140833 | Treating very preterm European infants with inhaled nitric oxide increased in-hospital mortality but did not affect neurodevelopment at 5 years of age. | Acta Paediatr | 2024 | https://conductscience.org/library/papers/38140833 | PubMed |
| 17 | 38565500 | Novel insights into minipuberty and GnRH: Implications on neurodevelopment, cognition, and COVID-19 therapeutics. | J Neuroendocrinol | 2024 | https://conductscience.org/library/papers/38565500 | PubMed |
| 18 | 25012863 | Activation of the hypothalamic-pituitary-gonadal axis in infancy: minipuberty. | Horm Res Paediatr | 2014 | https://conductscience.org/library/papers/25012863 | PubMed |
| 19 | 31050776 | Association of Socioeconomic Status and Brain Injury With Neurodevelopmental Outcomes of Very Preterm Children. | JAMA Netw Open | 2019 | https://conductscience.org/library/papers/31050776 | PubMed |
| 20 | 28056166 | Nitric oxide for respiratory failure in infants born at or near term. | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28056166 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40326486
GET https://conductscience.org/api/papers/v1/40326486/references?page=2